Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children. Manufactured by Biohaven Pharmaceuticals Inc. and sold at Pharmacies nationwide as a prescribed medicine from December 2021 – March 2023.

What you are looking at

Recalled Nurtec® ODT (rimegepant) orally disintegrating tablets

Image: CPSC recall notice Two more views

Check the label first

Compare every letter, number, space and suffix. A similar-looking product with a different suffix may not be part of this recall.

Affected model numbers

Why it was recalled

Incident reports to the firm

Injuries reported

SaferProducts.gov reports

None reported

The official remedy

Remedy type: repair

What to do

Consumers should immediately secure the recalled product out of the sight and reach of children and contact Pfizer for a free child resistant pouch to store the product. Once the product is secured, consumers can continue to use it as directed.

Product and sales details

ManufacturerBiohaven Pharmaceuticals Inc., of New Haven, Conn.

UnitsAbout 4.2 million

Made inUnited States

Sold atPharmacies nationwide as a prescribed medicine

Sales periodDecember 2021 – March 2023

How to reach the firm

Phone

800-879-3477

9 a.m. to 7 p.m. ET

Recall page

www.pfizer.com/contact

Verify phone numbers, hours and web addresses on the current CPSC notice before contacting the firm.